New imaging technology spots hidden cancer

February 4, 2026 - 11:01

A groundbreaking new tool is transforming the operating room, giving surgeons the ability to see cancer cells that are otherwise invisible to the naked eye. This FDA-approved technology involves a special imaging agent that is administered to the patient prior to surgery. Once in the body, the agent causes cancer cells to fluoresce, or glow, under near-infrared light.

During complex procedures, surgeons can switch the view through their goggles or monitor to see this real-time glow, which highlights the precise margins of cancerous tissue. This is particularly crucial for cancers that can be diffuse or blend in with healthy tissue, such as certain lung, breast, and gastrointestinal cancers. The primary goal is to achieve a more complete resection, removing all malignant cells while preserving as much healthy tissue as possible.

Experts highlight that this advancement represents a significant leap forward in surgical precision. By illuminating hidden cancer, the technology aims to reduce the need for follow-up surgeries and improve long-term patient outcomes. It provides a new layer of guidance, empowering surgical teams to make more informed decisions in real time, ultimately striving for better cancer control and patient recovery. The integration of such targeted imaging marks a promising new chapter in oncologic surgery.